ReviewFrontiers in endocrinology2023
Telemedicine for diabetes management during COVID-19: what we have learnt, what and how to implement.
Review in Frontiers in endocrinology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 29 citations in OpenAlex.
- Evaluation of mobile health applications using the RE-AIM model: systematic review and meta-analysis.Frontiers in public health · 2025Pooled it
- Efficacy of telemedicine intervention in the self-management of patients with type 2 diabetes: a systematic review and meta-analysis.Frontiers in public health · 2024Pooled it
- A bibliometric analysis of global trends in AI-driven digital health technologies for diabetes management.Medicine · 2026Article
- Evaluation of the Medical Utilization of the Telemedicine Pilot Project for Patients With Diabetes Based on Korean National Health Insurance Claims Data.Journal of Korean medical science · 2026Article
- Opportunities Offered by Telemedicine in the Care of Patients Affected by Fractures and Critical Issues: A Narrative Review.Journal of clinical medicine · 2025Review
- The Experience of Patients with Type 1 Diabetes Mellitus with the Use of Glucose Monitoring Systems: A Qualitative Study.Nursing reports (Pavia, Italy) · 2025Article
- Optimising cardiac surgery outcomes in people with diabetes: the OCTOPuS pilot feasibility study.Health technology assessment (Winchester, England) · 2025Article
- Bridging the digital divide: student-led literacy initiatives in diabetes management.Frontiers in clinical diabetes and healthcare · 2025Review
- Understanding the interplay between COVID-19 and diabetes: insights for the post-pandemic era.Frontiers in endocrinology · 2025Review
- Machine learning and deep learning in diabetology: revolutionizing diabetes care.Frontiers in clinical diabetes and healthcare · 2025Article
- A systematic analysis of the global disease burden of type 2 diabetes mellitus attributable to high intake of processed meat in 204 countries (1990-2021).Frontiers in endocrinology · 2025Article
- Telehealth in primary health care: a study of activities and time spent by professionals.Revista latino-americana de enfermagem · 2025Observational
- Telemedicine for Managing Type 1 Diabetes in Children and Adolescents Before and After the COVID-19 Pandemic.Journal of clinical medicine · 2024Review
- Impact of the COVID-19 Pandemic on Lifestyle Behavior and Clinical Care Pathway Management in Type 2 Diabetes: A Retrospective Cross-Sectional Study.Medicina (Kaunas, Lithuania) · 2024Article
- Challenges of using telemedicine for patients with diabetes during the COVID-19 pandemic: A scoping review.Journal of clinical & translational endocrinology · 2024Article
- The influence of telemedicine in primary healthcare on diabetes mellitus control and treatment adherence in Riyadh region.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
27 authors at 20 institutions in 16 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The past two decades have witnessed telemedicine becoming a crucial part of health care as a method to facilitate doctor-patient interaction. Due to technological developments and the incremental acquisition of experience in its use, telemedicine's advantages and cost-effectiveness has led to it being recognised as specifically relevant to diabetology. However, the pandemic created new challenges for healthcare systems and the rate of development of digital services started to grow exponentially. It was soon discovered that COVID-19-infected patients with diabetes had an increased risk of both mortality and debilitating sequelae. In addition, it was observed that this higher risk could be attenuated primarily by maintaining optimal control of the patient's glucose metabolism. As opportunities for actual physical doctor-patient visits became restricted, telemedicine provided the most convenient opportunity to communicate with patients and maintain delivery of care. The wide range of experiences of health care provision during the pandemic has led to the development of several excellent strategies regarding the applicability of telemedicine across the whole spectrum of diabetes care. The continuation of these strategies is likely to benefit clinical practice even after the pandemic crisis is over.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.